Home >> Marketplace Directory >> HTG Molecular Diagnostics and OvaGene Oncology partner, 6/14

HTG Molecular Diagnostics and OvaGene Oncology partner, 6/14

image_pdfCreate PDF

June 2014—HTG Molecular Diagnostics and OvaGene Oncology entered a manufacturing supply agreement in which OvaGene will design and develop its proprietary gene expression assays on HTG’s fully automated, extraction-free Edge Platform.

The Edge System uses one five-micron-thick formalin-fixed, paraffin-embedded section and is an extraction-free, automated gene expression platform that delivers multiplexed results on lysed samples in less than a day.

CAP TODAY
X